Antibodies against C1q in patients with systemic lupus erythematosus

Springer Seminars in Immunopathology

Volumn 27, Issue 3, 2005, Pages 276-285

  Trendelenburg, Marten ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; AUTOIMMUNE DISEASE; COMPLEMENT DEFICIENCY; COMPLEMENT SYSTEM; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTORY OF MEDICINE; HUMAN; HYPOCOMPLEMENTEMIA; IMMUNOPATHOLOGY; LUPUS ERYTHEMATOSUS NEPHRITIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIBODIES; COMPLEMENT C1Q; ENZYME-LINKED IMMUNOSORBENT ASSAY; HISTORY, 20TH CENTURY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MODELS, IMMUNOLOGICAL;

EID: 27844452822     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00281-005-0007-y     Document Type: Review

References (63)

1. Agnello V, Koffler D, Eisenberg JW, Winchester RJ, Kunkel HG (1971) C1q precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types. J Exp Med 134(Suppl):228-241
2. Antes U, Heinz HP, Loos M (1988) Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus. Arthritis Rheum 31:457-464
3. Barilla-LaBarca ML, Atkinson JP (2003) Rheumatic syndromes associated with complement deficiency. Curr Opin Rheumatol 15:55-60
4. Berner B, Scheel AK, Schettler V, Hummel KM, Reuss-Borst MA, Muller GA, Oestmann E, Leinenbach HP, Hepper M (2001 ) Rapid improvement of SLE-specific cutaneous lesions by C1q immunoadsorption. Ann Rheum Dis 60:898-899
5. Botto M, Walport MJ (2002) C1q, autoimmunity and apoptosis. Immunobiology 205:395-406
6. Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19:56-59
7. Cacoub P, Fremeaux-Bacchi V, De Lacroix I, Guillien F, Kahn MF, Kazatchkine MD, Godeau P, Piette JC (2001) A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus. Arthritis Rheum 44:1836-1840
8. Casciola-Rosen LA, Anhalt G, Rosen A (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179:1317-1330
9. Coremans IE, Spronk PE, Bootsma H, Daha MR, van der Voort EA, Kater L, Breedveld FC, Kallenberg CG (1995) Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis 26:595-601
10. Fremeaux-Bacchi V, Noel LH, Schifferli JA (2002) No lupus nephritis in the absence of anti-C1q autoantibodies? Nephrol Dial Transplant 17:2041-2043
11. Fremeaux-Bacchi V, Weiss L, Demouchy C, Blouin J, Kazatchkine MD (1996) Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus. Lupus 5:216-220
12. Gaboriaud C, Thielens NM, Gregory LA, Rossi V, Fontecilla-Camps JC, Arlaud GJ (2004) Structure and activation of the C1 complex of complement: unraveling the puzzle. Trends Immunol 25:368-373
13. Gaipl US, Kuenkele S, Beyer TD, Kolowos W, Heyder P, Kalden JR, Hermann M (2001) Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death. Cell Death Differ 8:327-334
14. Golan MD, Burger R, Loos M (1982) Conformational changes in C1q after binding of immune complexes: detection of neoantigens with monoclonal antibodies. J Immunol 129:445-447
15. Grimbert P, Schulte K, Buisson C, Desvaux D, Baron C, Pastural M, Dhamane D, Remy P, Weil B, Lang P (2001) Renal transplantation in a patient with hypocomplementemic urticarial vasculitis syndrome. Am J Kidney Dis 37:144-148
16. Gunnarsson I, Sundelin B, Heimburger M, Forslid J, van Vollenhoven R, Lundberg I, Jacobson SH (2002) Repeated renal biopsy in proliferative lupus nephritis-predictive role of serum C1q and albuminuria. J Rheumatol 29:693-699
17. Gunnarson I, Ronnelid J, Huang YH, Rogberg S, Nilsson B, Lundberg I, Klareskog L (1997) Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus. Br J Rheumatol 36:32-37
18. Gunnarson I, Ronnelid J, Lundberg I, Jacobson H (1997) Occurrence of anti-C1q antibodies in IgA nephropathy. Nephrol Dial Transplant 12:2263-2268
19. Haseley LA, Wisnieski JJ, Denburg MR, Michael-Grossman AR, Ginzler EM, Gourley MF, Hoffman JH, Kimberly RP, Salmon JE (1997) Antibodies to C1q in systemic lupus erythematosus: chracteristics and relation to FcRIIA alleles. Kidney Int 52:1375-1380
20. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR (1998) Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 41:1241-1250
21. Horvath L, Czirjak L, Fekele B, Jakab L, Pozsonyi T, Kalabay L, Romics L, Miklos K, Varga L, Prohaszka Z, Szakacs A, Nagy E, Daha MR, Fust G (2001) High levels of antibodies against C1q are associated with disease activity and nephritis but not with other organ manifestations in SLE patients. Clin Exp Rheumatol 19:667-672
22. Kohro-Kawata J, Wener MH, Mannik M (2002) The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus. J Rheumatol 29:84-89
23. Korb LC, Ahearn JM (1997) C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol 158:4525-4528
24. Kozyro I, Perahud I, Sadallah S, Sukalo AV, Titov LP, Schifferli JA, Trendelenburg M (2004) Clinical value of autoantibodies against C1q in children with glomerulonephritis. Kidney Blood Press Res 27:392
25. Mannik M, Wener M (1997) Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis. Arthritis Rheum 40:1504-1511
26. Martensson U, Sjoholm AG, Sturfelt G, Truedsson L, Laurell AB (1992) Western blot analysis of human IgG reactive with the collageneous portion of C1q: evidence of distinct binding specificities. Scand J Immunol 35:735-744
27. Martensson U, Thiel S, Jensenius JC, Sjoholm AG (1996) Human autoantibodies against C1q: lack of cross-reactivity with the collectins mannan-binding protein, lung surfactant protein A and bovine conglutinin. Scand J Immunol 43:314-320
28. Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA (2004) Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis 64(3):444-448. DOI 10.1136/ard.2004.024943
29. Mevorach D, Zhou JL, Song X, Elkon KB (1998) Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 188:387-392
30. Mevorach D, Mascarenhas JO, Gershov D, Elkon KB (1998) Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 188:2313-2320
31. Moroni G, Trendelenburg M, Del Papa N, Quaglini S, Raschi E, Panzeri P, Testoni C, Tincani A, Banfi G, Balestrieri G, Schifferli JA, Meroni PL, Ponticelli C (2001) Anti-C1q antibodies may help in diagnosing renal flare in lupus nephritis. Am J Kidney Dis 37:490-498
32. Navratil JS, Watkins SC, Wisnieski JJ, Ahearn JM (2001) The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells. J Immunol 166:3231-3239
33. Ogden CA, deCathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, Fadok VA, Henson PM (2001) C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic bodies. J Exp Med 194:781-796
34. Pfueller B, Wolbart K, Bruns A, Burmester GR, Hiepe F (2001) Successful treatment of patients with SLE by immunoadsorption with a C1q column: a pilot study. Arthritis Rheum 44:1962-1963
35. Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ (2000) Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 76:227-334
36. Potter PK, Cortes-Hernandez J, Quartier P, Botto M, Walport MJ (2003) Lupus-prone mice have an abnormal response to thioglycolate and an impaired clearance of apoptotic cells. J Immunol 170:3223-3232
37. Prada AE, Strife CF (1992) IgG subclass restriction of autoantibody to solid-phase C1q in membranoproliferative and lupus glomerulonephritis. Clin Immunol Immunopathol 63:84-88
38. Prohaszka Z, Daha MR, Susal C, Daniel V, Szlavik J, Banhegyi D, Nagy K, Varkonyi V, Horvath A, Ujhelyi E, Toth FD, Uray K, Hudecz F, Fust G (1999) C1q autoantibodies in HIV infection: correlation to elevated levels of autoantibodies against 60-kDa heat-shock proteins. Clin Immunol 90:247-255
39. Ravelli A, Wisnieski JJ, Ramenghi B, Ballardini G, Zonta L, Martini A (1997) IgG autoantibodies to complement C1q in pediatric-onset systemic lupus erythematosus. Clin Exp Rheumatol 15:215-219
40. Ronnelid J, Huang YH, Norrlander T, Rogberg S, Nilsson B, Gustafsson R, Klareskog L (1994) Short-term kinetics of the humoral anti-C1q response in SLE using ELISPOT method: fast decline in production in response to steroids. Scand J Immunol 40:243-250
41. Siegert CE, Daha MR, van der Voort EAM, Breedveld FC (1990) IgG and IgA antibodies to the collagen-like region of C1q in rheumatoid vasculitis. Arthritis Rheum 33:1464-1654
42. Siegert CE, Daha MR, Halma C, van der Voort EA, Breedveld FC (1992) IgG and IgA autoantibodies to C1q in systemic and renal diseases. Clin Exp Rheumatol 10:19-23
43. Siegert C, Daha M, Westedt ML, van der Voort E, Breedveld F (1991) IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J Rheumatol 18:230-234
44. Siegert CEH, Daha MR, Swaak AJG, van der Voort EAM, Breedveld FC (1993) The relationship between serum titres of autoantibodies against C1q and age in the general population and in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 67:204-209
45. Siegert CE, Daha MR, Tseng CM, Coremans IE, van Es LA, Breedveld FC (1993) Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus. Ann Rheum Dis 52:851-856
46. Siegert CE, Kazatchkine MD, Sjoholm A, Wurzner R, Loos M, Daha MR (1999) Autoantibodies against C1q: view on clinical relevance and pathogenic role. Clin Exp Immunol 116:4-8
47. Siegert CE, Daha MR, Lobatto S, van der Voort EA, Breedveld FC (1992) IgG autoantibodies to C1q do not detectably influence complement activation in vivo and in vitro in systemic lupus erythematosus. Immunol Res 11:91-97
48. Sjoholm AG, Martensson U, Sturfelt G (1997) Serial analysis of autoantibody responses to the collagen-like region of C1q, collagen type II, and double-stranded DNA in patients with systemic lupus erythematosus. J Rheumatol 24:871-878
49. Taylor PR, Carugati A, Fadok VA, Cook HT, Andrews M, Carroll MC, Savill JS, Henson PM, Botto M, Walport MJ (2000) A hierarchical role for classical pathway complement proteins in the clearance of apoptotic bodies in vivo. J Exp Med 192:359-366
50. Trendelenburg M, Courvoisier S, Spaeth PJ, Moll S, Mihatsch M, Itin P, Schifferli JA (1999) Hypocomplementemic urticarial vasculitis or systemic lupus erythematosus? Am J Kidney Dis 34:745-751
51. Trendelenburg M, Marfurt J, Gerber I, Tyndall A, Schifferli JA (1999) Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody negative patients. Arthritis Rheum 42:187-188
52. Trendelenburg M, Schifferli JA (1998) Is autoantibody determination in patients with systemic lupus erythematosus useful? Anti-C1q-autoantibody as an example. Schweiz Rundsch Med Prax 87:1811-1813
53. Trouw LA, Seelen MA, Duijs JMGJ, Benediktsson H, Van Kooten C, Daha MR (2003) Glomerular deposition of C1q and anti-C1q antibodies in mice following injection of anti-mouse C1q antibodies. Clin Exp Immunol 132:32-39
54. Trouw LA, Groeneveld TWL, Seelen MA, Dujis JMGJ, Bajema IM, Prins FA, Kishore U, Salant DJ, Verbeek JS, Van Kooten C, Daha MR (2004) Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J Clin Invest 114:679-688
55. Uwatoko S, Aotsuka S, Okawa M, Egusa Y, Yokohari R, Aizawa C, Suzuki K (1984) Characterisation of C1q-binding IgG complexes in systemic lupus erythematosus. Clin Immunol Immunopathol 30:104-116
56. Uwatoko S, Mannik M (1988) Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q. J Clin Invest 82:816-824
57. Uwatoko S, Gauthier VJ, Mannik M (1991) Autoantibodies to the collagen-like region of C1Q deposit in glomeruli via C1Q in immune deposits. Clin Immunol Immunopathol 61:268-273
58. Wener MH, Mannik M, Schwartz MM, Lewis EJ (1987) Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus. Medicine (Baltimore) 66:85-97
59. Wener MH, Uwatoko S, Mannik M (1989) Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases. Arthritis Rheum 32:544-551
60. Wisnieski JJ, Baer AN, Christensen J, Cupps TR, Flagg DN, Jones JV, Katzenstein PL, McFadden ER, McMillen JJ, Pick MA (1995) Hypocomplementemic urticarial vasculitis syndrome. Clinical and serological findings in 18 patients. Medicine (Baltimore) 74:24-41
61. Wisnieski JJ, Jones SM (1992) IgG autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus and six other skeletal or rheumatic diseases. J Rheumatol 19:884-888
62. Wisnieski JJ, Jones SM (1992) Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus. J Immunol 148:1396-1403
63. Yee CS, Hussein H, Skan J, Bowman S, Situnayake D, Gordon C (2003) Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus. Rheumatology 42:276-279